Marketing-authorisation holder · Brazil
Exeltis Laboratorio Farmaceutico Ltda
13 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Brazil
13 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
13 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| acetato de clomardinona + etinildestradiol | Clormadinona, Ethinyl estradiol | Brazil | Authorised | 2020 |
| desogestrel | Desogestrel | Brazil | Authorised | 2019 |
| EXELRING | Etonogestrel, Ethinyl estradiol | Brazil | Authorised | 2023 |
| GYNOTRAN | Metronidazole, Miconazole | Brazil | Authorised | 2018 |
| GYNPRO | Progesterone | Brazil | Authorised | 2020 |
| metronidazol + nitrato de miconazol | Metronidazole, Miconazole | Brazil | Authorised | 2026 |
| SLINDA | Drospirenone | Brazil | Authorised | 2021 |
| VIZURIA | Fosfomycin | Brazil | Authorised | 2023 |
| Cherry | Clormadinona, Ethinyl estradiol | Brazil | Cancelled | 2020 |
| DIVA | Drospirenone, Ethinyl estradiol | Brazil | Cancelled | 2017 |
| DIVA 20 | Drospirenone, Ethinyl estradiol | Brazil | Cancelled | 2018 |
| DROSPIRENONA + ETINILESTRADIOL | Drospirenone, Ethinyl estradiol | Brazil | Cancelled | 2017 |
| ULIP | Ulipristal | Brazil | Cancelled | 2017 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Brazil | 13 | 8 | 5 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Report an error or request removalCorrections from the company itself are welcome.